Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.57 +0.03 (+1.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Selling, General & Administrative (2020 - 2026)

Updated

Transcode Therapeutics (RNAZ) recorded Selling, General & Administrative of $2.54 million in Q2 2026, up 53.2% from $1.66 million a year earlier and up 14.1% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a TTM basis, Transcode Therapeutics' Selling, General & Administrative came in at $7.92 million as of Jun 30, 2026, up 58.5% year-over-year; for FY2025, it came in at $5.77 million, down 3.1% from FY2024.

  • Annual Selling, General & Administrative has declined for three straight years, though with a five-year compound annual growth rate of 67.2% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $5.95 million in FY2024 (-16.8%), $7.15 million in FY2023 (-14.8%), $8.4 million in FY2022 (+147.3%) and $3.4 million in FY2021 (+668.3%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q4 2022.
  • On a year-over-year basis, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 30.8% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 759.4% in Q1 2022, against a decline of 73.9% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.22 million (Q1 2026), $1.76 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Transcode Therapeutics 1.55 Mn 1.55 Mn - 2.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.54 Mn
Mar 31, 2026 2.22 Mn
Dec 31, 2025 1.76 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 951,652.00
Dec 31, 2024 1.45 Mn
Sep 30, 2024 938,026.00
Jun 30, 2024 2.03 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 733,962.00
Sep 30, 2023 1.97 Mn
Jun 30, 2023 2.16 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 2.81 Mn
Sep 30, 2022 1.91 Mn
Jun 30, 2022 2.09 Mn
Mar 31, 2022 1.60 Mn
Dec 31, 2021 1.70 Mn
Sep 30, 2021 1.37 Mn
API Access

Transcode Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RNAZ&period=max&api_key=YOUR_API_KEY